Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5′-ribofuran-uronamide moiety
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (3) , 596-601
- https://doi.org/10.1016/j.bmcl.2005.10.054
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Structure−Activity Relationships of 2-Chloro-N6-substituted-4‘-thioadenosine-5‘-uronamides as Highly Potent and Selective Agonists at the Human A3 Adenosine ReceptorJournal of Medicinal Chemistry, 2005
- The Cross-Species A3Adenosine-Receptor Antagonist MRS 1292 Inhibits Adenosine-Triggered Human Nonpigmented Ciliary Epithelial Cell Fluid Release and Reduces Mouse Intraocular PressureCurrent Eye Research, 2005
- PURINE RECEPTORS: GPCR STRUCTURE AND AGONIST DESIGNMolecular Interventions, 2004
- (N)-Methanocarba 2,N6-Disubstituted Adenine Nucleosides as Highly Potent and Selective A3 Adenosine Receptor AgonistsJournal of Medicinal Chemistry, 2004
- Structure–activity relationships of adenosine A3 receptor ligands: new potential therapy for the treatment of glaucomaBioorganic & Medicinal Chemistry Letters, 2004
- Modeling the Adenosine Receptors: Comparison of the Binding Domains of A2AAgonists and AntagonistsJournal of Medicinal Chemistry, 2003
- Synthesis, Biological Properties, and Molecular Modeling Investigation of the First Potent, Selective, and Water-Soluble Human A3 Adenosine Receptor AntagonistJournal of Medicinal Chemistry, 2002
- A Novel Class of Adenosine A3 Receptor Ligands. 2. Structure Affinity Profile of a Series of Isoquinoline and Quinazoline CompoundsJournal of Medicinal Chemistry, 1998
- Radiolabeling and efficient synthesis of tritiated 2-chloro-N6-(3-iodobenzyl)adenosine-5′-N-methyluron-amide, a potent, selective A3 adenosine receptor agonistJournal of Labelled Compounds and Radiopharmaceuticals, 1996
- Derivatives of the Triazoloquinazoline Adenosine Antagonist (CGS15943) Are Selective for the Human A3Receptor SubtypeJournal of Medicinal Chemistry, 1996